Coronavirus disease 2019 (COVID-19) is disrupting communities across the globe, causing physical, mental, and financial distress.1 Economic crises have been associated with increased alcohol consumption.2 Necessary public health measures may exacerbate isolation and stress, negatively impacting those who are at risk for harmful alcohol use. Increased alcohol use has been documented in the US and other countries during the pandemic, and a recent study3 has identified associated consequences. Alcohol withdrawal (AW) is a potentially dangerous complication of alcohol use disorder (AUD) in up to 8% of all hospitalized patients with AUD.4 AW has been suspected to worsen after the COVID-19 stay-at-home orders,5 but, to our knowledge, no objective data have been reported in the literature. We hypothesized that AW rates in hospitalized patients with AUD increased during the pandemic and conducted a cohort study at Christiana Care, a large, tertiary care hospital system in Newark, Delaware.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Accepted for Publication: January 11, 2021.
Published: March 3, 2021. doi:10.1001/jamanetworkopen.2021.0422
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Sharma RA et al. JAMA Network Open.
Corresponding Author: Ram A. Sharma MD, Department of Psychiatry, Christiana Care, 4735 Ogletown Stanton Rd, MAP 2, Ste 1201, Newark, DE 19713 (email@example.com).
Author Contributions: Dr Sharma had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Sharma, Subedi, Jurkovitz, Horton.
Acquisition, analysis, or interpretation of data: Sharma, Subedi, Gbadebo, Wilson, Jurkovitz.
Drafting of the manuscript: Sharma, Subedi.
Critical revision of the manuscript for important intellectual content: Sharma, Gbadebo, Wilson, Jurkovitz, Horton.
Statistical analysis: Sharma, Subedi.
Administrative, technical, or material support: Sharma, Wilson, Jurkovitz.
Supervision: Jurkovitz, Horton.
Conflict of Interest Disclosures: Dr Horton reported being a consultant for and serving on the advisory board of Masimo, a medical device company. No other disclosures were reported.
Funding/Support: Dr Jurkovitz is supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant numbers U54-GM104941 and P20-GM103446. Mr Subedi is supported by an IDeA from the National Institute of General Medical Sciences of the National Institutes of Health under grant number U54-GM104941 (Principal Investigator: Hicks).
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.
You currently have no searches saved.
You currently have no courses saved.